top of page

Dr. Neelima Khairatkar Joshi

Founder & President


  • Leader in Innovative Drug Discovery Research with 28 years of experience in multinational pharma including Hoechst Marion Roussel Ltd (Sanofi-Avantis now) and Glenmark Pharmaceuticals Ltd.

  • Well oriented to dynamics of global Healthcare, Life Sciences and New Drug Discovery approaches, strategies and space, including the NME discovery research (505(b)(1)) on various platforms of NCEs, NBEs, Cellular / Immune / Gene / mRNA therapeutics, differentiated branded specialty products (505(b)(2)) and drug repurposing approaches in various chronic diseases.

  • Served as Sr. Vice President and Head, NCE Research in a multinational Pharma Company for a decade.

  • Proven track-record of building from scratch, mentoring and overseeing a high-performance cross disciplinary discovery research team of over 150 scientists. Key leader in advancing eight novel molecules into clinical development, several being first in class.  Important player in six NCE out-licensing deals with pharma MNCs in Respiratory, Dermatology, Pain and Metabolic Disease therapy areas.

  • Expertise on ideation and preclinical development of new products for global branded specialty business. Key role in preclinical development of novel FDC product launched in multiple geographies including USA and Australia for allergic rhinitis

  • Inventor on 92 published world patents (PCTs)

  • Over 50 international presentations. Travelled extensively as invited oral speaker / poster presenter at key international meetings in Respiratory (ERS, ATS, SMi), Pain (SMi, WPC, WIA, SFN), Diabetes (ADA) areas.

  • Over 30 peer reviewed publications / book chapters (Elsevier, Expert Opinion, TRENDS and Molecular Medicine)

  • Invited / key note speaker / Panelist in key national meetings of Pharma policy makers (FICCI, CII), esteemed academia (IIT Roorkee, TIFR), industry expert on MSc biotech syllabus committee of IIT Mumbai

  • Professional Background: Held positions from Group Leader, VP / Function Head to Sr. VP / NCE Research Head at Glenmark Pharmaceuticals (2000-2020), Scientist at Hoechst Marion Roussel (Now Sanofi Aventis) (1993-2000)

  • Academic Background: Ph.D. in Molecular Biology from BARC, Mumbai (1992). Predoctoral research training at University of East Anglia, UK. Masters and Bachelors in Microbiology, University of Mumbai (1986 and 1984 respectively).

Our Team

Scientists with Ph D / Post- Doctoral Research qualification, rich experience and proven track record in new drug discovery research and branded specialty molecule ideation.

bottom of page